Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-04

Clinical Trial Update: Effectiveness of a Vaginal Gel on CIN1/2 Regression and HPV Clearance. [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 trial in women is evaluating a vaginal gel for CIN1/2 regression and HPV clearance; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vaginal Gel (investigational)

Snippet

Sponsor: University of Aarhus | Conditions: Womens Health, Cervical Dysplasia | EARLY_Phase 1 | Status: NOT_YET_RECRUITING